<DOC>
	<DOCNO>NCT00044252</DOCNO>
	<brief_summary>This study measure compare hormone level woman catamenial epilepsy ( epilepsy seizures frequent menstrual period ) , woman seizure related menstrual cycle , normal control subject . It determine whether difference among three group hormone level fast level change . It also examine relationship , , exist hormone change seizures woman catamenial epilepsy . The hormone study include gonadal hormone estrone , estradiol progesterone , neuroactive steroid allopregnanolone , pregnenolone , dehydroepiandrosterone . Women meet follow criterion may eligible 3-month study : - Between 18 45 year age , catamenial epilepsy - Between 18 45 year age , seizure , catamenial epilepsy - Between 18 45 year age , without seizure All participant physical examination begin study , clinic visit , completion withdrawal study . In addition , undergo follow procedure : Baseline Monitoring For first 2 month , participant keep diary temperature onset menses . Women epilepsy also record seizures . Electroencephalography ( EEG ) Healthy volunteer 45-minute EEG ( record electrical activity brain ) begin menstrual cycle day menses . Women epilepsy continuous EEG monitoring 8 day , begin 5 day menstrual period expect . The continuous monitoring do outpatient basis , use portable EEG recording device , inpatient , admission hospital 8 day record . Blood Sampling All participant small blood sample ( 2 teaspoon ) draw day day 10 , 14 , 17 , 19 21 menstrual cycle three time day day 6 period 8 day , start 5 day expect menses continue 3 day next cycle . For day three blood draw , small needle stay place 72 hour place arm avoid discomfort multiple needle stick .</brief_summary>
	<brief_title>Role Hormones Susceptibility Seizures Women With Epilepsy</brief_title>
	<detailed_description>Objectives . This initial pilot study acquire information upon specific , statistically rigorous follow-on investigation base . The objective overall project : ( 1 ) compare absolute level rate change level gonadal neuroactive steroid woman complex partial seizure catamenial epilepsy woman non-catamenial epilepsy woman volunteer without epilepsy , ( 2 ) determine fluctuation level gonadal hormone ( estrone , estradiol , progesterone ) neuroactive steroid ( allopregnanolone , pregnenolone dehydroepiandrosterone ) correlate seizure occurrence frequency interictal spikes/wave discharge woman catamenial seizure exacerbation . Study Populations . Group A : adult woman complex partial seizure catamenial exacerbation . Group B : adult woman complex partial seizure without catamenial seizure exacerbation . Group C : adult female volunteer without epilepsy . Design . Subjects undergo baseline monitoring seizures menses two month prior entry . Upon enrollment study , blood ( 10 ml ) drawn determination estradiol , estrone , progesterone , allopregnanolone , dehydroepiandrosterone ( DHEA ) pregnenolone study population daily 08:30 hr menstrual cycle day , 10 , 14 , 17 , 19 21 ; three time daily 08:30 , 13:30 18:00 start 5 day expect menses continue total 8 day well menstrual cycle day 6 . During 8 day start 5 day expect menses interictal spike activity seizure also monitor continuously EEG . Comparisons rate change hormone level spike seizure frequency make use time derivative fluctuation hormone level hormone level ratio . Comparisons time series data make use nonlinear regression arbitrary ( cubic spine ) model . Outcome Parameters . The goal preliminary study obtain data regard fluctuation , one menstrual cycle , several hormone epileptic non-epileptic woman reproductive age . If data show relationship ( ) fall level plasma progesterone allopregnanolone , ( ii ) increase level DHEA pregnenolone ( iii ) increase ratio estrogen/progesterone , DHEA/progesterone , DHEA/allopregnanolone , pregnenolone/allopregnanolone seizure manifestation EEG document interictal spike seizure activity would support hypothesis alteration level steroid hormone related seizure exacerbation woman catamenial epilepsy .</detailed_description>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Disease Susceptibility</mesh_term>
	<criteria>INCLUSION CRITERIA : Group A subject 8 woman 18 45 year age complex partial seizure Type 1 catamenial seizure exacerbation previously define . Group B subject 8 woman 18 45 year age complex partial seizure meet criterion catamenial seizure exacerbation . The presence absence Type 1 catamenial seizure exacerbation document standard seizure calendar selfreported least two consecutive menstrual cycle . Patients receive antiepileptic drug therapy continue medication . All subject must agree use double barrier contraceptive , intrauterine device place practice abstinence course study . Patients recruit epilepsy patient population National Institutes Health . Subjects group A B matched seizure frequency . Volunteers match subject group A age . In pilot study , attempt make match patient accord anticonvulsant medication . The patient properly inform nature risk study give informed consent writing , prior enter study . EXCLUSION CRITERIA : Any following condition cause exclusion study : Any illness requiring chronic drug therapy antiepileptic drug . Any history illness likely adversely affected trial . Psychiatric hospitalization last 2 month time prior study . Use tricyclic antidepressant within 4 week prior randomization and/or antipsychotic drug within 2 week prior randomization . Children include pilot study , profile hormonal secretion undergoes profound change puberty . Use illicit drug , alcoholism binge drink per medical history inventory . Women unwilling use alternative oral contraceptive contraception , ( double barrier contraceptive , intrauterine device abstinence ) , establish currently pregnant submit pregnancy test . Exposure investigational drug within 12 week prior randomization . Any history endocrine dysfunction . Women exclude regular menstrual cycle interval 27 32 day pregnant , nurse take oral contraceptive reproductive hormone . If need arise change antiepileptic regime study subject exclude replace another patient . Women currently take Phenobarbital another barbiturate . Women unwilling refrain strenuous exercise study . Women unwilling refrain usage herbal soy product .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 22, 2008</verification_date>
	<keyword>Neurosteroids</keyword>
	<keyword>Complex Partial Seizure</keyword>
	<keyword>Menstrual Cycle</keyword>
	<keyword>Allopregnanolone</keyword>
	<keyword>Catamenial Epilepsy</keyword>
	<keyword>Seizures</keyword>
	<keyword>Epilepsy</keyword>
	<keyword>Healthy Volunteer</keyword>
	<keyword>HV</keyword>
	<keyword>Normal Control</keyword>
</DOC>